Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page
- Check5 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating an incremental version update. It does not appear to alter study data or eligibility details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page shows a new revision tag indicating an updated study record (v3.6.3), replacing the previous version (v3.6.2).SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.6.2 appears, replacing the previous v3.6.0. This indicates a minor, administrative update to the page template or related content rather than changes to the study data.SummaryDifference0.0%

- Check48 days agoChange DetectedRecruitment for the study is now closed, and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added to help users navigate the record. In addition, the Intervention/Treatment header formatting was updated and the page revision tag updated to v3.6.0.SummaryDifference0.4%

- Check55 days agoChange DetectedA new Revision: v3.5.5 tag was added and the previous Revision: v3.5.4 tag removed, indicating a minor page update.SummaryDifference0.0%

- Check76 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' was removed. This indicates an update to the study documentation version, typically reflecting administrative edits rather than changes to core study content.SummaryDifference0.0%

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.